ライフサイエンスコーパス: rhesus

1 The KIR region in large cohorts of rhesus and cynomolgus macaque populations were character

2 We anticipated that the more aggressive rhesus and Japanese macaques would have lower serotonerg

3 eterm FM of humans with chorioamnionitis and rhesus and mouse IUI models.

4 Thus, our data from human, rhesus, and mouse demonstrates a critical role IRAK1 in

5 Another rhesus antibody bound the CD4 binding site by CD4 mimicr

6 The structure of one rhesus antibody, capable of neutralizing 49% of a 208-st

7 lated SIV(mac239)-gp120 core in complex with rhesus CD4 and the antigen-binding fragment of ITS90.03

8 immunodeficiency virus (SIV) Env to improve rhesus CD4 binding.

9 We characterized PKCdelta neurons in the rhesus CeL, compared its distribution with that of the m

10 Interferon-primed ISG15-knockout porcine and rhesus cells demonstrate enhanced ISG expression and pro

11 from a large number (N = 50) of disassembled rhesus cleavage-stage embryos.

12 ed with a human anti-CD3 specificity that is rhesus cross-reactive.

13 iral interleukin-10 (IL-10) manifest delayed rhesus cytomegalovirus (RhCMV) acquisition and altered i

14 Rhesus cytomegalovirus (RhCMV) strain 68-1-vectored simi

15 to reorganize the ER, while the homolog from rhesus cytomegalovirus shows neither activity.

16 s includes the choice of ABO blood group and Rhesus D status, the need for special requirements for s

17 Rhesus developed a greater inflammatory response than cy

18 As as putative attachment receptors, we used rhesus enteric caliciviruses (ReCVs) to study enteric ca

19 meases (Mep), and the more distantly related rhesus factors (Rh) are trimeric membrane proteins prese

20 /Mep/Rh transporters that includes the human Rhesus factors.

21 nding glycoprotein as a potent antagonist of rhesus FcgammaR activation.

22 Whereas allotypes of rhesus FcgammaR2A were identified with responses similar

23 nd lower (R131) affinity for IgG, all of the rhesus FcgammaR3A allotypes exhibited responses most sim

24 orter cell lines stably expressing human and rhesus FcgammaRs, we further demonstrate that Rh05 antag

25 nsporter (AMT)/methylammonium permease (MEP)/Rhesus glycoprotein (Rh) family of ammonia (NH(3)/NH(4)

26 Rhesus glycoproteins (Rh50) have been shown to be ammoni

27 will enable future studies to fully capture rhesus Ig and TCR repertoire diversity and is applicable

28 geted amplification strategies for profiling rhesus Ig and TCR repertoires are largely unknown.

29 ons of all known isotypes and chain types of rhesus Ig and TCR repertoires.

30 exists across the entire variable regions of rhesus Ig and TCR transcripts.

31 significant fraction (27-53% and 42-49%) of rhesus Ig/TCR diversity.

32 to each of the four subclasses of human and rhesus IgG and with Fc variants of IgG1 that enhance bin

33 ediated responses to different subclasses of rhesus IgG.

34 gp120 protein or with DNA for SIV genes and rhesus interleukin-12 plus SIV gp120 protein.

35 This clade includes rhesus isolate 10 (AAVrh.10) and 39 (AAVrh.39) which, un

36 For 10 groups of rhesus, long-tailed, and bonnet macaques, we collected s

37 Here, we infected a small group of male rhesus (Macaca mulatta) and cynomolgus (Macaca fascicula

38 The species examined included rhesus (Macaca mulatta), Japanese (M. fuscata), pigtaile

39 key species: vervets (Chlorocebus aethiops), rhesus macaque (Macaca mulatta) and cynomolgus macaque (

40 The rhesus macaque (Macaca mulatta) is the most widely studi

41 Male rhesus macaque (Macaca mulatta) morphological traits are

42 estimate of the de novo mutation rate in the rhesus macaque (Macaca mulatta) using whole-genome seque

43 a: cynomolgus macaque (Macaca fascicularis), rhesus macaque (Macaca mulatta), pig (Sus scrofa), and m

44 In this study, we show that strain 68-1 rhesus macaque (RM) CMV vaccine vectors expressing HBV A

45 n toward an HIV cure by depleted Tregs in 14 rhesus macaque (RM) controllers infected with SIVsab, th

46 oped a morphine dependent SIVmac251 infected Rhesus macaque (RM) model to study the impact of opioids

47 e used morphine dependent SIVmac251 infected rhesus macaque (RM) model to study the impact of opioids

48 monkey (AGM) to an AIDS susceptible species, rhesus macaque (RM).

49 We report rhesus macaque A3G structures that show different inter-

50 Recently, crystal structures of full-length rhesus macaque A3G variants were solved which suggested

51 The establishment of the rhesus macaque as a model of COVID-19 will increase our

52 estigated MAIT cell dynamics and function in rhesus macaque blood and bronchoalveolar lavage (BAL) fo

53 ity of this molecule to induce signaling via rhesus macaque CD200R, as well as the potential function

54 Fortunately, two such animal models-the rhesus macaque CMV and guinea pig CMV-are characterized

55 n developed an isolation technique to purify rhesus macaque eosinophils from peripheral blood and per

56 by the emergence of a novel KIR allele in a rhesus macaque family.

57 nes expressing common allotypes of human and rhesus macaque FcgammaR2A and FcgammaR3A were establishe

58 We sequenced Zika virus (ZIKV) from a rhesus macaque fetus that died after inoculation and ide

59 These studies reveal that rhesus macaque IgG responses during chronic SIV infectio

60 Rhesus macaque infants experienced on average 5% reduced

61 The rhesus macaque is an important animal model for AIDS and

62 The rhesus macaque is an important model species in several

63 Rhesus macaque is an Old World monkey that shared a comm

64 Canine, porcine, and rhesus macaque ISG15, such as human ISG15, stabilize USP

65 dy mass data collected from 253 free-ranging rhesus macaque Macaca mulatta infants on Cayo Santiago,

66 tly assess the binding of four common Indian rhesus macaque MHC class I molecules (Mamu-A1*001, -A1*0

67 Although the rhesus macaque model does not represent the severe disea

68 d in many, but not all, brain regions in the rhesus macaque model is consistent with the possible exi

69 Here, a rhesus macaque model of FASD, involving oral self-admini

70 We used an infant rhesus macaque model of HIV-1 infection via breastfeedin

71 ed MK-8591 as preexposure prophylaxis in the rhesus macaque model of intrarectal challenge with simia

72 In a preterm rhesus macaque model of IUI given intra-amniotic LPS, in

73 We developed a rhesus macaque model of SARS-CoV-2 infection and observe

74 investigate the efficacy of remdesivir in a rhesus macaque model of SARS-CoV-2 infection(9).

75 c and virologic efficacy of baricitinib in a rhesus macaque model of SARS-CoV-2 infection.

76 We utilized a rhesus macaque model of SHIV infection as a tool to dist

77 ct of ART on the gut microbiota, we used the rhesus macaque model of SIV infection to characterize an

78 e we show that postnatal ZIKV infection in a rhesus macaque model resulted in long-term behavioral, m

79 Using the rhesus macaque model, we tested a pharmacological inhibi

80 ept will ultimately have to be tested in the rhesus macaque model, which is shown here to have MUC16-

81 /Makona-C05, and Marburg virus/Angola in the rhesus macaque model.

82 In two male rhesus macaque monkeys (Macaca mulatta), we found that l

83 colon cells from SIV-infected and uninfected rhesus macaque monkeys and determined the make-up of the

84 sion-weighted MRI data before and after male rhesus macaque monkeys received extensive training to le

85 the microbiome of the captive reared infant rhesus macaque more closely resembles that of human infa

86 duction and maintenance of variation in male rhesus macaque morphometric traits which may be subject

87 TG and PG parameters from baboon and rhesus macaque plasma approximated that of humans.

88 und that neurons in a particular area of the rhesus macaque posterior thalamus encoded the historical

89 Together, the rhesus macaque recapitulates the moderate disease that h

90 d herpesvirus (KSHV) and the closely related rhesus macaque rhadinovirus (RRV) are unique for encodin

91 herpesvirus (KSHV), and the closely related rhesus macaque rhadinovirus (RRV).

92 Here, we used the rhesus macaque simian immunodeficiency virus model with

93 Using the rhesus macaque simian immunodeficiency virus SIVmac251 m

94 sequencing, we sequenced four Indian-origin rhesus macaque tissues and obtained high-quality, full-l

95 early organogenesis to adulthood for human, rhesus macaque, mouse, rat, rabbit, opossum and chicken.

96 rgic interneurons, in human, chimpanzee, and rhesus macaque.

97 man primate model of MERS-CoV infection, the rhesus macaque.

98 Rhesus macaques (Macaca mulatta) are key for modeling hu

99 Infant rhesus macaques (Macaca mulatta) are susceptible to diar

100 e transfer of purified IgG from convalescent rhesus macaques (Macaca mulatta) protects naive recipien

101 Fifty-two rhesus macaques (Macaca mulatta) were immunized with Ad2

102 have been created for humans (Homo sapiens), rhesus macaques (Macaca mulatta), and several other nonh

103 asma samples from C57BL/6J mice (n = 28) and rhesus macaques (n = 4) immunized with the same HCV E1E2

104 measured and quantified in 7 eyes of 4 male rhesus macaques (NHPs) using the Konigsberg EO system (c

105 odeficiency virus (SIV)/SHIV-infected infant rhesus macaques (RM) and tracked changes in frequency, t

106 Fifty percent of rhesus macaques (RM) vaccinated with a combined RhCMV-Ga

107 man interleukin-15 (rhIL-15) in SIV-infected rhesus macaques (RM).

108 that enable efficient replication in Indian rhesus macaques (RM).

109 Rhesus macaques (RMs) (n = 13) were infected with simian

110 Approximately 50% of rhesus macaques (RMs) expressing the major histocompatib

111 nodeficiency virus (SIV) vaccine regimens in rhesus macaques (RMs) has not been fully investigated.

112 ges in the two surviving, aged AGMs and four rhesus macaques (RMs) infected with SARS-CoV-2.

113 eated simian immunodeficiency virus-infected rhesus macaques (RMs) undergoing CD8alpha depletion and

114 Here, we identified 7 SIV(mac239)-infected rhesus macaques (RMs), defined as PTCs, who started ART

115 CD8(+) T cells targeting non-Env epitopes in rhesus macaques (RMs).

116 40 along with HIV envelope (Env) vaccines to rhesus macaques and bnAb immunoglobulin knock-in (KI) mi

117 ected from experimental iBCI measurements in rhesus macaques and from a clinical-trial participant wi

118 d oxytocin intranasally and intravenously to rhesus macaques and measure, with mass spectrometry, con

119 ere, in simian immunodeficiency virus (SIV)+ rhesus macaques and patients diagnosed with HIV, brain r

120 of natural textures across the fingertips of rhesus macaques and recorded the responses evoked in Bro

121 enomes in experimentally inoculated pregnant rhesus macaques and their fetuses.

122 15, researchers capitalized on the fact that rhesus macaques are commonly used to model viral immunit

123 Pregnant rhesus macaques at 127 days of gestation (80% of term) w

124 In study 3, at a 0.1-mg/kg dose, 2 rhesus macaques became infected, consistent with a 7.2-f

125 e addressed the susceptibility of two infant rhesus macaques born healthy to dams infected with Zika

126 port a vaccine-induced sex bias, with female rhesus macaques but not males displaying significantly r

127 against hard-to-neutralize SHIV challenge in rhesus macaques by inducing tier 2 nAbs, provided approp

128 Our results demonstrate that rhesus macaques can learn to use a middle concept for a

129 Here, we recorded from the BLA of two male rhesus macaques choosing between different juices.

130 Rhesus macaques conditioned to associate particular colo

131 Here we show that rhesus macaques experimentally coinfected simultaneously

132 nd gene networks active in adipose tissue of rhesus macaques following FGF21-induced weight loss.

133 -2196 or COV2-2381) as monotherapy protected rhesus macaques from SARS-CoV-2 infection.

134 to sites of viral reservoirs in SIV-infected rhesus macaques had no demonstrable effect on plasma vir

135 ctional MRI showed that ZIKV-infected infant rhesus macaques had persistent enlargement of lateral ve

136 y limits Mtb infection in highly susceptible rhesus macaques has important implications for vaccine d

137 Whole-genome sequencing (WGS) data from 853 rhesus macaques identified 85.7 million single-nucleotid

138 rimate model of HCMV infection, we show that rhesus macaques immunized against viral interleukin-10 (

139 intervention experiments with 59 adult male rhesus macaques indicated low plasma adropin concentrati

140 marrow-liver-thymus (BLT) humanized mice and rhesus macaques infected with HIV and SIV, respectively.

141 y during infection had a clinical benefit in rhesus macaques infected with SARS-CoV-2.

142 logic sections of lungs from both humans and rhesus macaques infected with SARS-CoV-2.

143 lysates and synaptosome preparations of male rhesus macaques infected with simian immunodeficiency vi

144 tudied 4 simian/HIV-infected, ART-suppressed rhesus macaques infused with virus-specific CD4CAR T cel

145 We show that five rhesus macaques initially infected with ZIKV 22 to 28 mo

146 We found that rhesus macaques inoculated with blood-stage Plasmodium c

147 Rhesus macaques intrabronchially inoculated with simian

148 ected from TB modelling studies performed in Rhesus macaques of Indian genotype (RM), cynomolgus maca

149 he reproductive success of high-ranking male rhesus macaques on Cayo Santiago.

150 Here, we used infant rhesus macaques orally infected with simian/human immuno

151 ectrophysiological recordings from two adult rhesus macaques performing a perceptual task and compara

152 odes in the dorsal premotor cortex of 2 male rhesus macaques performing a visual reaction time (RT) r

153 Capuchin monkeys and especially rhesus macaques persisted to trial completion even when

154 In study 1, 8 rhesus macaques received 3.9 mg/kg of MK-8591 orally on

155 Indian rhesus macaques received two doses of PIZV at varying co

156 n immunized with gp150 complexed to BMS-529, rhesus macaques showed neutralization against tier 2 pse

157 t SARS-CoV-2 causes a respiratory disease in rhesus macaques that lasts between 8 and 16 days.

158 Here, we identified 7 SIV-infected rhesus macaques that mirrored the human posttreatment co

159 y, peripheral ganglia were collected from 12 rhesus macaques that succumbed to Ebola virus (EBOV) dis

160 Here we show in rhesus macaques that the time elapsed after ZIKV infecti

161 lower respiratory tract tissue of vaccinated rhesus macaques that were challenged with SARS-CoV-2 com

162 knowledge gap, our laboratory studied infant rhesus macaques to evaluate how acute SIV/SHIV infection

163 rm of simian immunodeficiency virus (SIV) in rhesus macaques to investigate the generation and select

164 HIV infection, we randomly assigned newborn rhesus macaques to receive BCG vaccine or remain unvacci

165 anipulated long-term social status in female rhesus macaques to show that social subordination alters

166 Previously, we reported 60-75% survival of rhesus macaques treated with rVSV vectors expressing MAR

167 afted with human hepatocytes (hFRG mice) and rhesus macaques using a highly pathogenic African YFV st

168 PET scans in rhesus macaques were acquired for 2 h with arterial bloo

169 (n = 4) or chronically (n = 12) SIV-infected rhesus macaques were analyzed by flow cytometry using co

170 All rhesus macaques were challenged with SHIV109CP3 on day 6

171 Brain-dead (n = 12) and sham (n = 5) rhesus macaques were maintained for 20 hours under inten

172 Rhesus macaques were primed twice mucosally with replica

173 , provided protection from SUDV infection in rhesus macaques when administered at 50 mg/kg on days 4

174 These data were confirmed in rhesus macaques where a low dose of TMV-NPNAx5 elicited

175 We vaccinated 30 rhesus macaques with Ad26-SIV Env/Gag/Pol and SIV Env gp

176 The authors found that treating rhesus macaques with ART restored CD4+ T cells in whole

177 Vaccination of rhesus macaques with bivalent VLPs generated strong humo

178 To accomplish this, we prime-boosted rhesus macaques with clade C NFL trimers and identified

179 ple anatomical sites in chronically infected rhesus macaques with high (>10,000 copies/mL plasma) or

180 es in the mesenteric lymph nodes relative to rhesus macaques with high VLs.

181 Rhesus macaques with low viral loads (VLs) harbored high

182 ent and function of CCR5(+)CD8(+) T cells in rhesus macaques with or without Simian immunodeficiency

183 is or immune dysfunction, we treated healthy rhesus macaques with protease, integrase, or reverse tra

184 In total, the synovium of 28 of 30 rhesus macaques with terminal filovirus disease had evid

185 In this study, we rechallenged five rhesus macaques with ZIKV 22 to 28 months after a primar

186 human immunodeficiency virus (SHIV)-infected rhesus macaques, an earlier and sharper decline in viral

187 The tracer was also studied in rhesus macaques, and PET images were analyzed with an ar

188 ficient for protection against SARS-CoV-2 in rhesus macaques, and that cellular immune responses may

189 us 2 (SARS-CoV-2) infection in young and old rhesus macaques, baboons and old marmosets.

190 In rhesus macaques, BMS-529 complexed to CD4 bs-targeting c

191 in 3 species and found that the response in rhesus macaques, but not in mice, closely resembled that

192 dendritic cells (pDCs) and CD141(+) DCs from rhesus macaques, compared to the induction of apoptosis

193 and polyfunctional V2-focused Ab response in rhesus macaques, described herein.

194 genic, alone and in combination, in mice and rhesus macaques, inducing IgG antibodies that mediated o

195 of infecting and replicating efficiently in rhesus macaques, resulting in peripheral viral kinetics

196 orphism of detrusor function is prominent in rhesus macaques, shares many features with the human, an

197 used into viremic simian HIV (SHIV)-infected rhesus macaques, there was a 21% difference in slope of

198 Using SIV-infected rhesus macaques, we analyzed multiple brain regions thro

199 ng-term antiretroviral therapy (ART)-treated rhesus macaques, we demonstrate that PD-1, CTLA-4 and du

200 ted functional MRI data from humans and from rhesus macaques, we first identified an asymmetrical res

201 ral ganglia and results in ganglionopathy in rhesus macaques, which may contribute to the neurologica

202 o efficacy of this antibody cocktail in both rhesus macaques, which may model mild disease, and golde

203 eukocytes and alveolar epithelial cells, and rhesus macaques, without noticeable toxicity.

204 by simian-human immunodeficiency viruses in rhesus macaques-elicited patterns of Env-antibody coevol

205 ku-Mayinga infection during acute disease in rhesus macaques.

206 tered prophylactically or therapeutically in rhesus macaques.

207 enhance protection against SIV infection in rhesus macaques.

208 ce imaging and neurocognitive assessments in rhesus macaques.

209 ponse of type-1 and type-2 T helper cells in rhesus macaques.

210 produce robust HIV-1-specific antibodies in rhesus macaques.

211 eractions, transmission, and pathogenesis in rhesus macaques.

212 re observed in the prostate of ZIKV-infected rhesus macaques.

213 2 spike (S) protein and evaluated them in 35 rhesus macaques.

214 arts, and lungs, in humans, chimpanzees, and rhesus macaques.

215 les in SHIV.C.CH505-infected, ART-suppressed rhesus macaques.

216 egravir plasma concentration of 373 ng/ml in rhesus macaques.

217 essure flow studies in 16 male and 22 female rhesus macaques.

218 ons with a combination of DNA and protein in rhesus macaques.

219 rain regions across humans, chimpanzees, and rhesus macaques.

220 atory syndrome coronavirus 2 (SARS-CoV-2) in rhesus macaques.

221 inst SIVmac251 challenges in naive recipient rhesus macaques.

222 vaccinia virus Ankara (MVA)-SHIV vaccines in rhesus macaques.

223 thsin (Q-GRFT) in rectal tissue samples from rhesus macaques.

224 lateral or medial subdivisions of the OFC in rhesus macaques.

225 ynamics and immunopathology of SHIV.CH505 in rhesus macaques.

226 cy virus (SIV) infection of adult humans and rhesus macaques.

227 rtial protection against viral challenges in rhesus macaques.

228 alue per implant, N = 41) of cabotegravir in rhesus macaques.

229 aping the probability distortion patterns of rhesus macaques: we presented 2 male monkeys with binary

230 tic potential of ISG15-deficient porcine and rhesus models.

231 ACE2 of human/rhesus monkey and rat/mouse exhibited the highest and lo

232 tures that contact mitotic NPCs in the fetal rhesus monkey but not in rat.

233 We describe here the development of a rhesus monkey model of AD using soluble oligomers of the

234 y analyzed the gene expression profiles in 2 rhesus monkey recipients using peripheral blood RNA-sequ

235 This study, using a rhesus monkey renal transplantation model, sought to det

236 replication-competent, recombinant strain of rhesus monkey rhadinovirus (RRV) expressing the Gag prot

237 The related rhesus monkey rhadinovirus (RRV) has shown potential as

238 atitis virus (VSV), adenovirus type 5 (Ad5), rhesus monkey rhadinovirus (RRV), and DNA again.

239 ribution of GABA(A) receptor subunits in the rhesus monkey was highly heterogeneous indicating a high

240 ions of periventricular microglia in rat and rhesus monkey, yet are consistent with the concept that

241 on tensor images were collected in 581 young rhesus monkeys (1.89 +/- 0.77 years old; 43.9% female).

242 Here we address whether rhesus monkeys (Macaca mulatta) can learn the abstract c

243 lices of ventral premotor cortex (vPMC) from rhesus monkeys (Macaca mulatta) of either sex, we demons

244 ion to social cognition is causal by testing rhesus monkeys (Macaca mulatta) on a vicarious reinforce

245 and delta) in the fore brain of three female rhesus monkeys (Macaca mulatta).

246 axon terminals to (inputs) the ACC of adult rhesus monkeys (Macaca mulatta).

247 experiments using electrical stimulation in rhesus monkeys (Macaca mulatta).

248 ent methods of slow delivery immunization of rhesus monkeys (RMs) resulted in more robust T follicula

249 tions were compared in 12 healthy young male rhesus monkeys (~1-2 y old, ~3 +/- 1 kg).

250 duced comparable peak immune responses in 30 rhesus monkeys as in humans and resulted in an 83% (95%

251 Methods: PET imaging was performed on rhesus monkeys at baseline and after administration of e

252 Two rhesus monkeys conducted instructed walk-and-reach movem

253 ing neural responses in the visual cortex of rhesus monkeys during a motion direction change detectio

254 k, we used a visual cue to instruct two male rhesus monkeys either to repeat their most recent choice

255 Eighteen rhesus monkeys euthanized between 3 and 8 days post-infe

256 of viral rebound in chronically SIV-infected rhesus monkeys following ART discontinuation.

257 16 ART-suppressed, chronically SIV-infected rhesus monkeys following ART discontinuation.

258 n immunodeficiency virus (SHIV) infection of rhesus monkeys is an important preclinical model for hum

259 s mechanistic and neuroimaging work in young rhesus monkeys linked the central nucleus of the amygdal

260 Aging rhesus monkeys naturally develop cognitive deficits, amy

261 In rhesus monkeys of both sexes, we investigated how these

262 e recording cellular activity in PFC of male rhesus monkeys performing a delayed decision task requir

263 smitter GABA in regulating delay activity in rhesus monkeys performing a delayed decision task requir

264 cal functional connectivity is altered after rhesus monkeys received extensive training to learn nove

265 Four rhesus monkeys self-administered i.v. infusions of fenta

266 zapine, and deschloroclozapine, in four male rhesus monkeys tested in a spatial delayed response task

267 and we performed a pool competition study in rhesus monkeys to define the optimal variant for each SH

268 re microscopy and RNA sequencing in 47 young rhesus monkeys to investigate AT's molecular underpinnin

269 To address these questions, we trained rhesus monkeys to perform a novel decision-making task w

270 context modulate strategy, we trained 2 male rhesus monkeys to perform a novel perceptual decision-ma

271 We trained rhesus monkeys to perform a two-stage decision task desi

272 We also did a parallel preclinical study in rhesus monkeys to test the protective efficacy of the sh

273 body imaging of (89)Zr-labeled antibodies in rhesus monkeys up to 30 d after injection.

274 idual neurons in the middle temporal area of rhesus monkeys using a task that allowed us to isolate t

275 Here, we model a worst-case scenario using rhesus monkeys vaccinated or unvaccinated with the rVSV-

276 activity using a strategy task in which two rhesus monkeys were instructed by a visual cue either to

277 different levels of visual cortex of 2 male rhesus monkeys while the animals did a visual discrimina

278 o ethanol-enhanced GABA release in abstinent rhesus monkeys with a history of chronic ethanol self-ad

279 mparative approach, we assessed capuchin and rhesus monkeys' susceptibility to sunk costs in a psycho

280 ained from 28 healthy humans, 10 baboons, 12 rhesus monkeys, 20 Yorkshire pigs, 20 Sprague-Dawley rat

281 during the day in both healthy and diabetic rhesus monkeys, peaking between 12 noon - 6 pm.

282 on, attenuates heroin self-administration in rhesus monkeys, suggesting it could be an effective trea

283 We recently showed, in aged female rhesus monkeys, that systemic administration of MSC-EVs

284 cacy of one of the short vaccine regimens in rhesus monkeys.

285 s inoculation of two Mamu-A*01 (+) RRV-naive rhesus monkeys.

286 diolabeled with (11)C and studied in vivo in rhesus monkeys.

287 e control of disjunctive saccades in trained rhesus monkeys.

288 c effects against SARS-CoV-2 are observed in rhesus monkeys.

289 pheral immune cells during EBOV infection in rhesus monkeys.

290 g against HIV infection, in hemiparkinsonian rhesus monkeys.

291 Rhesus-negative (Rh-) blood type was protective against

292 Among bonnet macaques, but not rhesus or long-tailed macaques, individuals who were mor

293 ammonium transporter/methylammonium permease/rhesus protein (Amt/Mep/Rh) family of transporters.

294 The ABO and rhesus (Rh) blood groups may influence risk for severe a

295 In the murine model of BA, rhesus rotavirus (RRV) infection of newborn pups results

296 gestation fetuses proved to be resistant to rhesus rotavirus (RRV) mediated liver inflammation.

297 Rhesus rotavirus (RRV)-mediated experimental BA was indu

298 overcome these limitations, we designed new rhesus-specific assays that remove the need for primers

299 Surprisingly, we found that both human and rhesus TRIM5alpha efficiently repress human LINE-1 retro

300 Previously, rhesus TRIM5alpha has been shown to efficiently block HI